Please enable Javascript
HealthDay News
HealthDay News is a content partner with GU Oncology Now.
Articles by HealthDay News
⁶⁸Ga-PSMA PET/CT, PET/MRI Accurate for LN Involvement
HealthDay News
RLT
|
September 20, 2022
Both imaging diagnostics are accurate for detecting lymph node involvement in prostate cancer.
Read More
COVID-19 Vaccine-Related Positive LNs Seen With Radiopharmaceuticals
HealthDay News
RLT
|
September 20, 2022
The incidence was seen with the use of 18F-fluorocholine PET/CT and 68Ga-PSMA-11 PET/CT.
Read More
Implementing PSMA-PET Into Focal Dose RT Is Feasible
HealthDay News
RLT
|
July 5, 2022
Implementing molecular imaging into focal dose radiation is feasible in intermediate-, high-risk prostate cancer patients.
Read More
PSMA-PET Parameters Linked to Clinical Risk Factors in Prostate Cancer
HealthDay News
RLT
|
July 5, 2022
None of the investigated imaging parameters significantly outperformed maximum standardized uptake value.
Read More
High Rate of Distant Metastases ID'd After PSMA-PET-Guided sRT
HealthDay News
RLT
|
June 21, 2022
An analysis of recurrence patterns on PET after sRT showed abdominal-lymphatic and distant metastatic patterns.
Read More
Fluorine-18 PSMA Noninferior to Gallium-68 PSMA for Detecting Prostate Cancer
HealthDay News
RLT
|
June 21, 2022
miPSMA expression score was higher for 18F-PSMA-11 than 68Ga-PSMA-11.
Read More
Gallium-68 PSMA-11 PET Has Higher Diagnostic Accuracy Before Treatment
HealthDay News
RLT
|
February 5, 2024
Diagnostic accuracy is significantly better for baseline imaging than for images obtained after systemic therapy.
Read More
PSMA PET Predictive of Outcomes in BCR After Radical Prostatectomy
HealthDay News
RLT
|
May 24, 2022
PSMA PET and high EAU risk are linked to worse event-free survival in patients who received salvage radiation treatment.
Read More
⁶⁸Ga-PSMA-11 PET/CT Superior to ⁹⁹ᵐTc-MDP BS for ID'ing Bone Metastases
HealthDay News
RLT
|
May 24, 2022
68Ga-PSMA-11 PET/CT detects bone metastases in 22.3% of patients with negative 99mTc-MDP BS results, study finds.
Read More
Novel Framework Prognostic for Overall Survival in mCRPC
HealthDay News
RLT
|
May 24, 2022
RECIP 1.0, incorporating PSMA PET/CT, can assess tumor response early in course of 177Lu-PSMA therapy.
Read More
MRI-ADC, [⁶⁸Ga]Ga-PSMA-11 PET Can Differentiate ISUP Grades
HealthDay News
RLT
|
May 24, 2022
Best model based on [68Ga]Ga-PSMA-11 PET had prediction efficiency of 95% in training phase, 100% in test phase.
Read More
Biochemical Recurrence Drops With PSMA-PET/CT Before SRT
HealthDay News
RLT
|
September 20, 2022
PSMA PET/CT for biochemical recurrence performed prior to SRT linked to improved outcomes for patients with prostate cancer.
Read More
⁶⁸Ga-PSMA PET/CT Promising for Lymph Node Staging in Prostate Cancer
HealthDay News
RLT
|
September 20, 2022
⁶⁸Ga-PSMA PET/CT has promising diagnostic accuracy for lymph node staging before radical prostatectomy, study shows.
Read More
⁶⁸Ga-PSMA PET/CT Bests mpMRI in Detecting High-Risk Prostate Cancer
HealthDay News
RLT
|
September 20, 2022
⁶⁸Ga-PSMA PET/CT improves detection of high-risk prostate cancer compared with multiparametric magnetic resonance ...
Read More
PSMA-PET/CT Affects Choice of Radiation Therapy in Prostate Cancer
HealthDay News
RLT
|
September 20, 2022
PSMA-PET/CT findings affect treatment decisions and selection of radiation therapy in the management of prostate cancer.
Read More
Newer Hormone Treatments for Prostate Cancer May Raise Risk of Depression
HealthDay News
Prostate Cancer
|
January 19, 2022
Newer forms of hormone therapy are effective at keeping prostate cancer in check but also can increase risk of depression.
Read More
Black Men Get Better Outcomes From Radiation Rx for Prostate Cancer
HealthDay News
Prostate Cancer
|
September 19, 2022
Analysis shows that radiation therapy seems to work better for Black men with prostate cancer than for their White peers.
Read More
Unemployment Adversely Linked to Recommended Cancer Screening
HealthDay News
Prostate Cancer
|
September 19, 2022
Unemployment is adversely linked to recommended cancer screening, and the link is explained by lack of health insurance.
Read More
PSMA PET Supports EAU Risk Groups for Biochemically Recurrent Prostate Cancer
HealthDay News
RLT
|
September 20, 2022
Men with high risk BCR according to EAU Prostate Cancer Guidelines Panel and BCP have higher rates of metastatic disease.
Read More
PSMA PET/CT-Based RT Yields Good Survival for Lymph Node Metastases
HealthDay News
RLT
|
September 20, 2022
The results are promising in comparison to other studies.
Read More
Load More